YOHIMBINE HYDROCHLORIDE TAB 2MG DIN 00885533
Health Canada record
| Active ingredient(s) | YOHIMBINE HYDROCHLORIDE 2 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | G04BE04 YOHIMBIN |
| Original market date | 31-Dec-1992 |
| Current status date | 04-Jun-2020 |
| Source | Health Canada DPD |
Establishment licence of the holder
Odan Laboratories Ltd. — licence 100025, currently licensed, last inspection rating C (2024-03-12).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing YOHIMBINE HYDROCHLORIDE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00865907 | ANTAGONIL INJ 5MG/ML | WILDLIFE LABORATORIES, INC. | Liquid | YOHIMBINE HYDROCHLORIDE 5 MG | Cancelled Post Market |
| 00795283 | YOCON TABLET 5.4MG | PALISADES PHARMACEUTICALS INC. | Tablet | YOHIMBINE HYDROCHLORIDE 5.4 MG | Cancelled Post Market |
| 01954504 | YOHIMBINE HCL 2MG | ODAN LABORATORIESLTD | Tablet | YOHIMBINE HYDROCHLORIDE 2 MG | Cancelled Post Market |
| 01954342 | YOHIMBINE HCL 5.4MG | ODAN LABORATORIESLTD | Tablet | YOHIMBINE HYDROCHLORIDE 5.4 MG | Cancelled Post Market |
| 02049155 | YOHIMBINE HYDROCHLORIDE TABLETS 5.4MG | TANTA PHARMACEUTICALS INC | Tablet | YOHIMBINE HYDROCHLORIDE 5.4 MG | Cancelled Post Market |
| 01901885 | YOHIMBINE TAB 5.4MG | ODAN LABORATORIESLTD | Tablet | YOHIMBINE HYDROCHLORIDE 5.4 MG | Cancelled Post Market |
| 00843512 | YOHIMBINE TAB 6MG | ROUGIER PHARMA DIVISION OF RATIOPHARM INC | Tablet | YOHIMBINE HYDROCHLORIDE 6 MG | Cancelled Post Market |
| 01985604 | YOHIMBINE-ODAN 6MG | ODAN LABORATORIESLTD | Tablet | YOHIMBINE HYDROCHLORIDE 6 MG | Cancelled Post Market |
International API supply for YOHIMBINE HYDROCHLORIDE
0 active FDA Drug Master Files.
Request a quote for YOHIMBINE HYDROCHLORIDE TAB 2MG